Market Overview

Hematology analyzers in this research indicate the following nine categories: Automated biochemical analyzers that conduct biochemical tests out of specimen inspection devices, dry chemistry systems, electrolyte analyzers, glucose analyzers, blood gas analyzers for physiological tests, blood cell counters for hematologic tests, blood coagulation analyzers, immunological analyzers, and glycated hemoglobin analyzers (high performance liquid chromatograph).
The domestic hematology analyzers market for 2020 as a total of 9 categories (based on the shipment values at manufacturers) declined by 0.9% from the previous year to attain 56,920 million yen. In recent years, the market size has kept being the same level. Slowdown in equipment sales attributes to the decrease in the number of hospitals, and the fact that purchases are chiefly done as replacements; such analyzing instruments are already installed at hospital facilities and clinical laboratories.
In spite of the setbacks by the spread of COVID-19 infections, including declined demand for clinical examinations, loss of sales opportunities and delays of instrument installations, some product categories saw expansion in 2020. 

Noteworthy Topics

Notable Growth Not Expected Even With Increased Focus on Some Product Categories

The year 2020 was significantly affected by the outbreak of COVID-19, which brought economic downturn and changes in social activities. For the hematology analyzers market, rise in demand was anticipated particularly for the blood gas analyzers that assess severity of COVID-19 infections, the blood coagulation analyzers in connection with thrombosis, and the blood cell counters for measuring the number of blood cells like white blood cells. The field of immunological analyzers also garnered attention as some manufacturers launched COVID-19 antigen detection reagents.
Although special demand rose for some immunological analyzers, for other product categories, negative factors had much greater impact, which include decline in clinical examination demand due to diminishing number of patients as well as slowdown in sales activities and delays of instrument installation at medical institutions. As a result, the market growth is flat to modest increase.

Future Outlook

The domestic hematology analyzers market for 2021 as a total of 9 categories (based on the shipment values at manufacturers) is projected to attain 56,380 million yen (down 0.9% from the previous year). Even though the market expects recovery from the drop in demand for clinical examination and stagnation in sales activities due to the spread of COVID-19 infections, since special demand that some manufacturers enjoyed is likely to come to an end, notable growth is not expected for the entire market. From 2021 onward, the market continues to level off, supported mainly by replacement demand. Size of the market is estimated to be 56,680 million yen by 2024, down 0.4% from 2020.

Research Outline